Professor Finbarr O'Harte holds a BSc Hons and PhD from Queen’s University Belfast. He was a Research Fellow at Creighton University, Omaha, USA (1989-91), University College Cork (1992-93) and Ulster University  (1993-95) before taking up an academic appointment as Lecturer in Human Nutrition at Ulster University in 1995. He was promoted to Reader in 2000 and Professor of Endocrinology and Metabolism in 2005. Finbarr is a patent holder and academic co-founder of Diabetica Limited, an Ulster University start-up company focused on innovative diabetes therapeutics. He has over 200 peer-reviewed publications (h-index 36 on Scopus) with many presentations at national and international conferences and was recipient of the Nordisk Medal of the Irish Endocrine Society (2005). He has held the position of the President of the Irish Endocrine Society (2015-2018). Research Interests include structurally modified peptides in therapy and drug development. Regulatory peptides in control of feeding and obesity. Incretin hormone analogues in diabetes therapy. Glucagon receptor antagonists in diabetes therapy. Bioactive peptides form marine sources. Functional food ingredients. Teaching Interests include Diabetes Metabolism and Therapeutics. Hormone Action and Endocrinology. Administrative Roles: Module Co-ordinator for Biochemistry (BMS102),  MRes pathway leader for Biomedical Sciences.  MSc Research Project in Biomedical Sciences DL (BMS809).